> top > docs > PMC:7195088 > spans > 67307-67803 > annotations

PMC:7195088 / 67307-67803 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1952 150-158 Species denotes patients Tax:9606
1953 206-214 Species denotes patients Tax:9606
1959 333-351 Chemical denotes hydroxychloroquine MESH:D006886
1962 170-196 Disease denotes respiratory tract symptoms MESH:D012140
1963 226-252 Disease denotes respiratory tract symptoms MESH:D012140

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T116 164-187 Body_part denotes upper respiratory tract http://purl.org/sig/ont/fma/fma45661
T117 220-243 Body_part denotes lower respiratory tract http://purl.org/sig/ont/fma/fma45662

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T51 164-187 Body_part denotes upper respiratory tract http://purl.obolibrary.org/obo/UBERON_0001557
T52 170-187 Body_part denotes respiratory tract http://purl.obolibrary.org/obo/UBERON_0000065
T53 220-243 Body_part denotes lower respiratory tract http://purl.obolibrary.org/obo/UBERON_0001558
T54 226-243 Body_part denotes respiratory tract http://purl.obolibrary.org/obo/UBERON_0000065

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T369 61-66 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T370 105-107 http://purl.obolibrary.org/obo/CLO_0053794 denotes 41
T371 125-126 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T372 220-243 http://purl.obolibrary.org/obo/UBERON_0001558 denotes lower respiratory tract
T373 306-307 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T33985 133-138 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T99 333-351 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T474 0-496 Sentence denotes Although based on low-level evidence, the positive effect of virus clearance observed by Gautret et al. [41] was observed in a mixed group of non-ICU patients with upper respiratory tract symptoms, non-ICU patients with lower respiratory tract symptoms and asymptomatic subjects, which overall may support a positive effect of early hydroxychloroquine initiation in non-ICU settings (although information on the exact time of treatment initiation with respect to symptoms onset was not provided).